[Morbidity and hospital cost reduction in cardiac surgery using a presurgery ambulatory strategy]

Nydia Ávila-Vanzzini1, Jorge Kuri-Alfaro, Laura Leticia Rodríguez-Chávez

  • 1Departamento de Ecocardiografía. Instituto Nacional de Cardiología Ignacio Chávez.

Insights

The fast track to hospitalization program significantly reduced major adverse events and hospital stay for cardiac surgery patients. This approach offers substantial cost savings for hospitals.

Area of Science:

  • Cardiovascular Surgery
  • Hospital Administration
  • Patient Flow Optimization

Background:

  • Elective cardiac surgery patients are typically admitted via a waiting list.
  • A fast track to hospitalization program was implemented in 1999 for low-risk patients and extended in 2004 to moderate-risk patients.
  • This program aims to streamline the admission process based on established protocols and institutional experience.

Purpose of the Study:

  • To compare the outcomes of fast track to hospitalization versus the traditional admission department waiting list.
  • To evaluate major adverse events, including death, prolonged hospital stay (>14 days), infections, and reoperations.
  • To assess differences in hospitalization duration and associated hospital costs.

Main Methods:

  • Two groups of 347 patients were analyzed: one utilizing the fast track program and the other the traditional waiting list.
  • Fast track patients were required to complete preoperative studies and manage comorbidities before admission.
  • Monetary costs were calculated based on patient socioeconomic classification; statistical analysis included Student t-tests and Chi-square tests (p < 0.05 significance).

Main Results:

  • While overall mortality was similar (4.3% vs. 5.8%), the fast track group had significantly fewer major events (73 vs. 97, p=0.032) and mediastinitis (2 vs. 9, p=0.033).
  • Hospitalization duration was significantly shorter in the fast track group (11 days vs. 20 days, p=0.0001).
  • The pre-surgical time was markedly reduced in the fast track group (2 days vs. 9 days, p=0.0001).

Conclusions:

  • The fast track to hospitalization program is associated with lower postoperative morbidity, particularly a significant reduction in mediastinitis.
  • Shorter pre-surgical intervals in the fast track group are linked to reduced exposure to nosocomial pathogens.
  • This streamlined admission process resulted in a 32% cost saving for the hospital due to decreased length of stay.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...